Endpoint Clinical has been recognized as a Leader in the 2025 Everest Group Life Sciences Randomization and Trial Supply Management (RTSM) Products PEAK Matrix® Assessment. This distinction reflects ...
The report offers key market opportunities in PTSD clinical trials by providing insights into global trial distribution, enrollment trends, and prominent drugs. It aids in identifying strategic ...
Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...
The Clinical Data Research Report shows data managers are currently losing an estimated 12 hours per week per study to ...
View all available purchase options and get full access to this article. Supported by the National Health and Medical Research Council (NHMRC) Postgraduate Scholarship (APP2005294) to N.D.M, Emerging ...
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...
The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes ...
As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...
More than 74,000 people have had their lives disrupted by Trump administration cuts to clinical trials supported by the ...
Last month, the National Academies of Science, Engineering, and Medicine (“NASEM”) issued a report discussing the inclusion of pregnant and lactating people in clinical research and the health impacts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback